Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Ridker

Showing results (11-20 of 203) with videos related to

Pageof 21
Sort By:
Thrombosis and Haemostasis|July 1, 1997
Fibrinolytic and inflammatory markers for arterial occlusion: the evolving epidemiology of thrombosis and hemostasisP M Ridker
American Family Physician|May 1, 1989
Health hazards of unusual herbal teasP M Ridker
Annals of Internal Medicine|June 22, 1999
Evaluating novel cardiovascular risk factors: can we better predict heart attacks?P M Ridker
Advances in Internal Medicine|January 15, 2000
Novel risk factors and markers for coronary diseaseP M Ridker
Journal of Internal Medicine|November 26, 2018
Anti-inflammatory therapy for atherosclerosis: interpreting divergent results from the CANTOS and CIRT clinical trialsP M Ridker
European Heart Journal|March 21, 1998
C-reactive protein and risks of future myocardial infarction and thrombotic strokeP M Ridker
Archives of Environmental Health|May 1, 1987
Toxic effects of herbal teasP M Ridker
Haemostasis|January 1, 1997
Intrinsic fibrinolytic capacity and systemic inflammation: novel risk factors for arterial thrombotic diseaseP M Ridker
Current Cardiology Reports|August 23, 2000
Are statins anti-inflammatory? Issues in the design and conduct of the pravastatin inflammation C-reactive protein evaluationP M Ridker
Clinical Cornerstone|May 9, 2000
Inherited risk factors for venous thromboembolism: implications for clinical practiceP M Ridker
Pageof 21

Showing results (11-20 of 203) with videos related to

Sort By:
Pageof 21
Thrombosis and Haemostasis|July 1, 1997
Fibrinolytic and inflammatory markers for arterial occlusion: the evolving epidemiology of thrombosis and hemostasisP M Ridker
American Family Physician|May 1, 1989
Health hazards of unusual herbal teasP M Ridker
Annals of Internal Medicine|June 22, 1999
Evaluating novel cardiovascular risk factors: can we better predict heart attacks?P M Ridker
Advances in Internal Medicine|January 15, 2000
Novel risk factors and markers for coronary diseaseP M Ridker
Journal of Internal Medicine|November 26, 2018
Anti-inflammatory therapy for atherosclerosis: interpreting divergent results from the CANTOS and CIRT clinical trialsP M Ridker
European Heart Journal|March 21, 1998
C-reactive protein and risks of future myocardial infarction and thrombotic strokeP M Ridker
Archives of Environmental Health|May 1, 1987
Toxic effects of herbal teasP M Ridker
Haemostasis|January 1, 1997
Intrinsic fibrinolytic capacity and systemic inflammation: novel risk factors for arterial thrombotic diseaseP M Ridker
Current Cardiology Reports|August 23, 2000
Are statins anti-inflammatory? Issues in the design and conduct of the pravastatin inflammation C-reactive protein evaluationP M Ridker
Clinical Cornerstone|May 9, 2000
Inherited risk factors for venous thromboembolism: implications for clinical practiceP M Ridker
Pageof 21